Cargando…
Tissue Inhibitor Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Kinetics Following Exposure to High-Dose Methotrexate
Urinary TIMP2×IGFBP7 (uTIMP2×IGFBP7) concentrations experienced a rapid and sustained decline after high-dose methotrexate (MTX) exposure. uTIMP2×IGFBP7 kinetics and concentrations after high-dose MTX exposure demonstrated no utility in predicting AKI.
Autores principales: | Barreto, Jason N., Barreto, Erin F., Mara, Kristin C., Rule, Andrew D., Lieske, John C., Giesen, Callen D., Thompson, Carrie A., Leung, Nelson, Witzig, Thomas E., Kashani, Kianoush B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278852/ https://www.ncbi.nlm.nih.gov/pubmed/36888987 http://dx.doi.org/10.34067/KID.0000000000000099 |
Ejemplares similares
-
A Prospective Evaluation of Novel Renal Biomarkers in Patients With Lymphoma Receiving High-Dose Methotrexate
por: Barreto, Jason N., et al.
Publicado: (2022) -
Propsective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function
por: Barreto, Jason N., et al.
Publicado: (2021) -
Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic
por: Markos, James Roland, et al.
Publicado: (2020) -
Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function
por: Barreto, Jason N., et al.
Publicado: (2018) -
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
por: Frazee, Erin N, et al.
Publicado: (2014)